Master the Evolving Care of Mitral and Tricuspid Valve Disease With Case-Based CME

For a decade now, Cleveland Clinic has been offering a heart valve-focused live CME event in December at a New York City venue just steps from Central Park. This year the focus of the day-and-a-half-course returns to mitral valve disease and tricuspid valve disease with “Case-Based Management of Mitral and Tricuspid Valve Disease” on Fri.-Sat., Dec. 4-5, 2026, at the JW Marriott Essex House in midtown Manhattan.

“Diagnosis and treatment of mitral and tricuspid valve disease are in evolution, and understanding the opportunities and pitfalls of novel approaches is important,” says course co-director Brian Griffin, MD, Section Head of Cardiovascular Imaging at Cleveland Clinic. “This course will provide insights into nuances that are critical to care delivery for these prevalent and interesting conditions.”

“Advances in these areas mean new options for patients,” adds course co-director Marc Gillinov, MD, Chair of Thoracic and Cardiovascular Surgery. “Using a case-based approach, we will highlight the advances and their applications.”

A thoroughly case-based curriculum

With a mix of short lectures and case discussions, expert multidisciplinary faculty will share evidence and practice insights in eight topical sessions covering the following:

• The changing landscape of mitral valve disease
• Management of tricuspid valve disease
• Ventricular arrhythmias and mitral regurgitation
• Atrial arrhythmias and mitral regurgitation
• The latest in transcatheter edge-to-edge repair (TEER)
• Ischemic mitral regurgitation
• Torrential tricuspid regurgitation
• When and how to address the mitral valve in hypertrophic obstructive cardiomyopathy

All sessions feature one or two case presentations with perspectives on case management from multiple disciplines and subspecialties, including cardiovascular imaging, interventional cardiology, surgery and electrophysiology. Each case presentation concludes with a recap of what happened to the patient and a panel discussion with attendee Q&A.

The course culminates in a final session exploring case-based management approaches to five complex clinical scenarios. The focus of the scenarios gives a sense of the course’s level of nuance:

• Critical care management in the setting of acute decompensated valvular heart disease
• Severe mitral regurgitation after TEER with persistent or recurrent symptoms
• Mitral valve dysfunction with underlying mitral annular calcification (MAC)
• Percutaneous valve management in MAC
• Management of cardiac implantable electronic device leads in tricuspid valve intervention

Drawing on expertise and connections across subspecialties

Key emphases throughout the agenda include the complex interplay between valvular pathology and cardiac arrhythmias, the role of multimodality imaging, relative advantages and drawbacks of surgical and transcatheter therapies, evidence-based decision-making and the value of multidisciplinary collaboration.

“The fundamentals of appropriate patient selection and detailed imaging-driven planning also will figure prominently throughout,” says course co-director Milind Desai, MD, MBA, Vice Chair of Education for Cleveland Clinic’s Heart, Vascular & Thoracic Institute.

The core faculty of more than a dozen Cleveland Clinic experts in various cardiovascular disciplines will be supplemented with a couple of guests from other leading institutions.

“Continued evolution of mitral and tricuspid valve disease care makes this course as relevant as ever,” observes course co-director Lars Svensson, MD, PhD, Chief of the Heart, Vascular & Thoracic Institute. “Its case study-based review of imaging and treatments will serve as a helpful introduction to managing the challenges of these conditions.”

Register or learn more at ccfcme.org/mitralvalve. Early-bird pricing ends after Nov. 1.

This activity has been approved for AMA PRA Category 1 Credit™.